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•  Since 2011 the Food and Drug Administration (FDA) has 
released over 80 drug approvals and/or new indications for 
Cancer.
•  This number is expected to rise as science, technology and 
therapeutics advance with a more personalized approach to 
Cancer Care.
•  In 2014, all 10 of newly FDA approved drugs worked by 
attacking the cancer on the molecular level.
•  Immune-mediated adverse reactions are common in patients treated with immunotherapies.
•  Since 2011, Lehigh Valley Health Network has opened more than 20 clinical trials including 
immunotherapies.
•  Combined with approval of ipilumumab in 2011, and pembrolizumab and nivolumab in 2014, the 
number of patients receiving immunotherapy has increased.
Background
•  Written and verbal feedback of staff reported an increase in knowledge of 
immunotherapies and their adverse events following the in-services.
•  Patients are reporting signs and symptoms of immune-mediated adverse 
reactions leading to direct hospital admission for prompt management with 
corticosteroids.
Evaluation
•  Innovative strategies to educate staff and patients are needed to provide 
quality care to a growing population of patients receiving immunotherapy.
•  The adverse events of immunotherapy are common and much different 
than chemotherapy or radiation side effects.
•  To maintain patient safety, it is imperative for nurses to recognize the 
symptoms.
•  Oncology nurse leaders continue to provide staff education and in-
services as needed.
Discussion
To educate staff and patients on immune-mediated 
adverse event.
•  Inpatient and outpatient nurses identified the topic of immunotherapy and 
adverse events for education during a learning needs assessment
   –  Oncology nurse leaders provided in-services to staff specific to the drugs 
with a large concentration on immune-mediated adverse reactions.
Interventions
In-Services
From: Programmed Cell Death-1 (PD-1) 
Pathway Checkpoint Inhibition: Immuno-
oncology for Advanced Melanoma, 2011.
Mechanism of Action
•  The Lehigh Valley Health Network (LVHN) Cancer Program Patient 
Education also identified a need for patient education material.
   –  A patient education book 
was developed to provide 
unique information related to 
immunotherapy, specifically 
how to recognize immune-
mediated adverse reactions.
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LVHN Doses of Immunotherapy





2011 57 0 57
2012 21 0 21
2013 35 22 57
2014 58 62 120
2015 78 493 571
2016* 31 249 280
TOTAL DOSES 280 826 1106
Excerpt from 
Patient Education
Purpose
Significance & Background
